These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 8983343)
1. Hypersensitization of multidrug resistant human ovarian carcinoma cells by pluronic P85 block copolymer. Alakhov VYu ; Moskaleva EYu ; Batrakova EV; Kabanov AV Bioconjug Chem; 1996; 7(2):209-16. PubMed ID: 8983343 [TBL] [Abstract][Full Text] [Related]
2. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA. Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833 [TBL] [Abstract][Full Text] [Related]
3. Reversal of P-glycoprotein-mediated multidrug resistance by protopanaxatriol ginsenosides from Korean red ginseng. Choi CH; Kang G; Min YD Planta Med; 2003 Mar; 69(3):235-40. PubMed ID: 12677527 [TBL] [Abstract][Full Text] [Related]
4. Discovery and characterization of OC144-093, a novel inhibitor of P-glycoprotein-mediated multidrug resistance. Newman MJ; Rodarte JC; Benbatoul KD; Romano SJ; Zhang C; Krane S; Moran EJ; Uyeda RT; Dixon R; Guns ES; Mayer LD Cancer Res; 2000 Jun; 60(11):2964-72. PubMed ID: 10850444 [TBL] [Abstract][Full Text] [Related]
5. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells. Liu ZL; Hirano T; Tanaka S; Onda K; Oka K J Pharm Pharmacol; 2003 Nov; 55(11):1531-7. PubMed ID: 14713364 [TBL] [Abstract][Full Text] [Related]
6. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318. Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852 [TBL] [Abstract][Full Text] [Related]
7. Dual mechanism of daunorubicin-induced cell death in both sensitive and MDR-resistant HL-60 cells. Côme MG; Skladanowski A; Larsen AK; Laurent G Br J Cancer; 1999 Mar; 79(7-8):1090-7. PubMed ID: 10098741 [TBL] [Abstract][Full Text] [Related]
8. Cross-resistance to the synthetic retinoid CD437 in a paclitaxel-resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor-gamma. Kumar A; Soprano DR; Parekh HK Cancer Res; 2001 Oct; 61(20):7552-5. PubMed ID: 11606393 [TBL] [Abstract][Full Text] [Related]
9. Interactions of pluronic block copolymers with brain microvessel endothelial cells: evidence of two potential pathways for drug absorption. Miller DW; Batrakova EV; Waltner TO; Alakhov VYu ; Kabanov AV Bioconjug Chem; 1997; 8(5):649-57. PubMed ID: 9327127 [TBL] [Abstract][Full Text] [Related]
10. 5-Azacytidine modulates the response of sensitive and multidrug-resistant K562 leukemic cells to cytostatic drugs. Efferth T; Futscher BW; Osieka R Blood Cells Mol Dis; 2001; 27(3):637-48. PubMed ID: 11482878 [TBL] [Abstract][Full Text] [Related]
11. Relation among the resistance factor, kinetics of uptake, and kinetics of the P-glycoprotein-mediated efflux of doxorubicin, daunorubicin, 8-(S)-fluoroidarubicin, and idarubicin in multidrug-resistant K562 cells. Mankhetkorn S; Dubru F; Hesschenbrouck J; Fiallo M; Garnier-Suillerot A Mol Pharmacol; 1996 Mar; 49(3):532-9. PubMed ID: 8643093 [TBL] [Abstract][Full Text] [Related]
12. [The relationship between multi-drug resistance gene expression and drug resistance of ovarian carcinoma]. Zhu L; Lang J; Shen K Zhonghua Fu Chan Ke Za Zhi; 1997 Aug; 32(8):462-6. PubMed ID: 9639738 [TBL] [Abstract][Full Text] [Related]
13. Hypersensitizing effect of pluronic L61 on cytotoxic activity, transport, and subcellular distribution of doxorubicin in multiple drug-resistant cells. Venne A; Li S; Mandeville R; Kabanov A; Alakhov V Cancer Res; 1996 Aug; 56(16):3626-9. PubMed ID: 8705995 [TBL] [Abstract][Full Text] [Related]
14. Discovery of a daunorubicin analogue that exhibits potent antitumor activity and overcomes P-gp-mediated drug resistance. Fang L; Zhang G; Li C; Zheng X; Zhu L; Xiao JJ; Szakacs G; Nadas J; Chan KK; Wang PG; Sun D J Med Chem; 2006 Feb; 49(3):932-41. PubMed ID: 16451059 [TBL] [Abstract][Full Text] [Related]
15. Effect of pO2 on antitumor drug cytotoxicity on MDR and non-MDR variants selected from the LoVo metastatic colon carcinoma cell line. Lelong-Rebel I; Brisson C; Fabre M; Bergerat JP; Rebel G Anticancer Res; 2008; 28(1A):55-68. PubMed ID: 18383825 [TBL] [Abstract][Full Text] [Related]
16. Drug resistance induced by ouabain via the stimulation of MDR1 gene expression in human carcinomatous pulmonary cells. Brouillard F; Tondelier D; Edelman A; Baudouin-Legros M Cancer Res; 2001 Feb; 61(4):1693-8. PubMed ID: 11245485 [TBL] [Abstract][Full Text] [Related]
17. Fluoxetine inhibits multidrug resistance extrusion pumps and enhances responses to chemotherapy in syngeneic and in human xenograft mouse tumor models. Peer D; Dekel Y; Melikhov D; Margalit R Cancer Res; 2004 Oct; 64(20):7562-9. PubMed ID: 15492283 [TBL] [Abstract][Full Text] [Related]
18. A new in vivo method to study P-glycoprotein transport in tumors and the blood-brain barrier. Hendrikse NH; de Vries EG; Eriks-Fluks L; van der Graaf WT; Hospers GA; Willemsen AT; Vaalburg W; Franssen EJ Cancer Res; 1999 May; 59(10):2411-6. PubMed ID: 10344751 [TBL] [Abstract][Full Text] [Related]
19. Reversal of doxorubicin resistance in multidrug resistant melanoma cells in vitro and in vivo by dipyridamole. Desai PB; Duan J; Sridhar R; Damle BD Methods Find Exp Clin Pharmacol; 1997 May; 19(4):231-9. PubMed ID: 9228648 [TBL] [Abstract][Full Text] [Related]
20. A rapid and sensitive flow cytometric method for the detection of multidrug-resistant cells. Herweijer H; van den Engh G; Nooter K Cytometry; 1989 Jul; 10(4):463-8. PubMed ID: 2766891 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]